GE Healthcare Announces FDA Approval For Mobile Mammography Screening Device

Main Category: Breast Cancer
Also Included In: MRI / PET / Ultrasound;  Regulatory Affairs / Drug Approvals
Article Date: 28 Aug 2007 - 3:00 PDT

email to a friend   printer friendly   opinions  

GE Healthcare on Wednesday announced that it has received FDA approval for its mobile mammography screening device, Reuters reports. The device will make it easier to increase screening for breast cancer in rural areas, Reuters reports (Reuters, 8/22). According to a GE release, the Senographe Essential device will improve access to mammography screening worldwide (GE release, 8/22).

According to a study published in the June 15 issue of the journal Cancer, the proportion of U.S. women age 40 and older who said they have undergone a mammogram in the previous two years declined from 70% to 66% from 2000 to 2005 (Kaiser Daily Women's Health Policy Report, 5/14).

"GE's goal is to enhance breast care for women worldwide and bring this technology to those who otherwise would not have access to it," David Caumartin, general manager of Global Mammography for GE Healthcare, said. He added, "GE offers customers the broadest portfolio when it comes to breast imaging, and the new mobile Essential will be the top-of-the-line mobile product in the market featuring all the proven advantages of our Senographe platform" (GE release, 8/22).

"Reprinted with permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation . © 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.

• Additional
• References
• Citations